147 related articles for article (PubMed ID: 11856487)
1. Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma.
Yoshida J; Mizuno M; Nakahara N; Colosi P
Jpn J Cancer Res; 2002 Feb; 93(2):223-8. PubMed ID: 11856487
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
[TBL] [Abstract][Full Text] [Related]
3. Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model.
GuhaSarkar D; Neiswender J; Su Q; Gao G; Sena-Esteves M
Mol Oncol; 2017 Feb; 11(2):180-193. PubMed ID: 28098415
[TBL] [Abstract][Full Text] [Related]
4. Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta.
Meijer DH; Maguire CA; LeRoy SG; Sena-Esteves M
Cancer Gene Ther; 2009 Aug; 16(8):664-71. PubMed ID: 19197327
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.
Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J
Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain.
Yagi K; Hayashi Y; Ishida N; Ohbayashi M; Ohishi N; Mizuno M; Yoshida J
Biochem Mol Biol Int; 1994 Jan; 32(1):167-71. PubMed ID: 8012282
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in glioma cells and upregulation of Fas expression using the human interferon-β gene.
Guo Y; Wang G; Gao WW; Cheng SW; Wang R; Ju SM; Cao HL; Tian HL
Asian Pac J Cancer Prev; 2012; 13(6):2837-40. PubMed ID: 22938469
[TBL] [Abstract][Full Text] [Related]
12. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
Volak A; LeRoy SG; Natasan JS; Park DJ; Cheah PS; Maus A; Fitzpatrick Z; Hudry E; Pinkham K; Gandhi S; Hyman BT; Mu D; GuhaSarkar D; Stemmer-Rachamimov AO; Sena-Esteves M; Badr CE; Maguire CA
J Neurooncol; 2018 Sep; 139(2):293-305. PubMed ID: 29767307
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
Xu G; Guo Y; Seng Z; Cui G; Qu J
Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
[TBL] [Abstract][Full Text] [Related]
14. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.
Bai CZ; Choi S; Nam K; An S; Park JS
Int J Pharm; 2013 Mar; 445(1-2):79-87. PubMed ID: 23384727
[TBL] [Abstract][Full Text] [Related]
15. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.
Ma HI; Guo P; Li J; Lin SZ; Chiang YH; Xiao X; Cheng SY
Cancer Res; 2002 Feb; 62(3):756-63. PubMed ID: 11830530
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of intracerebral rat glioma by transfection-induced human interferon-beta.
Harada K; Yoshida J; Mizuno M; Kurisu K; Uozumi T
J Surg Oncol; 1995 Jun; 59(2):105-9. PubMed ID: 7776650
[TBL] [Abstract][Full Text] [Related]
17. Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells.
Mizuno M; Yoshida J
Cancer Immunol Immunother; 1998 Dec; 47(4):227-32. PubMed ID: 9875676
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy.
Shinoura N; Koike H; Furitu T; Hashimoto M; Asai A; Kirino T; Hamada H
Hum Gene Ther; 2000 May; 11(8):1123-37. PubMed ID: 10834615
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
[TBL] [Abstract][Full Text] [Related]
20. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.
Natsume A; Tsujimura K; Mizuno M; Takahashi T; Yoshida J
J Neurooncol; 2000 Apr; 47(2):117-24. PubMed ID: 10982152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
